2fold: Investing for impact, Episode 12 with Andrew Denton

Andrew Denton reflects on his most memorable interviews, advocacy with Go Gentle for end-of-life choice, personal mental health challenges, and relationships with families driving voluntary assisted dying reform, with humour throughout.

Stay up to date

Join 20,000+ subscribers for market insights, top stock picks, and social impact updates from the Future Generation network.

Regarded as one of Australia’s best interviewers, Andrew Denton has spent more than two decades captivating audiences with hard-hitting questions and thought-provoking commentary. In this episode, we ask Andrew about his favourite moments behind the mic and his campaigning with Go Gentle, his charity that works to promote choice at the end of life for terminally ill Australians. While it’s not without a few laughs, the conversation also covers Andrew’s own mental health challenges and his relationship with the families behind the fight for voluntary assisted dying laws.

Please note that the views, information, or opinions expressed during the 2fold: Investing for Impact series are solely those of the speakers and do not necessarily represent the views or positions of any entities they represent.

Listen time 40 minutes.

Read the transcript.

Available on all major streaming platforms:


 

 

Recommendations

Lowe: We have a redistribution agenda, not a growth agenda

The Future Generation chairs tackle the big questions facing the Australian economy.

Philip Lowe blasts redistribution agenda at the heart of Jim Chalmers’s budget tax changes

The Australian coverage of Dr Philip Lowe's comments during the 'What's next for the Australian economy?' Future Generation Webinar

‘No from us’: Antipodes avoids SpaceX but likes this AI stock instead

Vihari Ross talks about the market’s hottest IPO, where she’s spotting opportunity to ride the chip boom and why she cashed out of Hyundai.

Plato, Munro invest in SpaceX as rival funds wait for the sellers

Munro Partners and Plato Investment Management are among the few Australian growth funds to invest in Elon Musk’s SpaceX IPO while most of their rivals are sitting back until the world’s hottest stock becomes cheaper.